CRISM Therapeutics Corp (CRTX) NPV
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
23.50p
23.40p
29.00p
£7.68 million
23.50p
22.00p
5.25p
n/a
0.00p (0.00%) Previous:
0.00p
10,476
n/a
15,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue (£m) | n/a | 0.04 |
| Profit before tax (£m) | (0.59) | (0.20) |
| Adjusted EPS (p): | (0.01) | (1,225.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataRecent dividends paid or declared by CRISM Therapeutics Corp:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| Special | 01/06/2023 | 14/06/2023 | 1.80p |
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyDividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
Company news for this stock is not available.
-
Final Results for the year ended 31 December 2024
13 June 2025 07:00
-
Best Paper Award
9 June 2025 07:00
-
Establishment of Scientific Advisory Board
3 June 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.